Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 3/2019

Ausgabe 3/2019

Inhaltsverzeichnis ( 16 Artikel )

06.02.2019 | Review | Ausgabe 3/2019

Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors

Ernest Nadal, Bartomeu Massuti, Manuel Dómine, Rosario García-Campelo, Manuel Cobo, Enriqueta Felip

01.12.2018 | Original Article | Ausgabe 3/2019 Open Access

The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma

Boyang Chang, Tao Huang, Huajun Wei, Lujun Shen, Duo Zhu, Wenjun He, Qifeng Chen, Huihua Zhang, Yunjian Li, Ruopan Huang, Wang Li, Peihong Wu

06.12.2018 | Original Article | Ausgabe 3/2019

CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions

Wanghong Hu, Zhenguo Zi, Yanling Jin, Gaoxin Li, Kang Shao, Qiliang Cai, Xiaojing Ma, Fang Wei

13.12.2018 | Original Article | Ausgabe 3/2019

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model

Diana Llopiz, Marta Ruiz, Lorea Villanueva, Tamara Iglesias, Leyre Silva, Josune Egea, Juan J. Lasarte, Perrine Pivette, Véronique Trochon-Joseph, Bérangère Vasseur, Graham Dixon, Bruno Sangro, Pablo Sarobe

14.12.2018 | Original Article | Ausgabe 3/2019

Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8+ T cells from negative regulation by local IFN-γ

Lin Lin, Patricia Rayman, Paul G. Pavicic Jr., Charles Tannenbaum, Thomas Hamilton, Alberto Montero, Jennifer Ko, Brian Gastman, James Finke, Marc Ernstoff, C. Marcela Diaz-Montero

18.12.2018 | Original Article | Ausgabe 3/2019

Identification and characterization of an alternative cancer-derived PD-L1 splice variant

Nadia B. Hassounah, Venkat S. Malladi, Yi Huang, Samuel S. Freeman, Ellen M. Beauchamp, Shohei Koyama, Nicholas Souders, Sunil Martin, Glenn Dranoff, Kwok-Kin Wong, Chandra S. Pedamallu, Peter S. Hammerman, Esra A. Akbay

18.12.2018 | Original Article | Ausgabe 3/2019 Open Access

A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression

Kathleen M. Mahoney, Sachet A. Shukla, Nikolaos Patsoukis, Apoorvi Chaudhri, Edward P. Browne, Arnon Arazi, Thomas M. Eisenhaure, William F. Pendergraft III, Ping Hua, Hung C. Pham, Xia Bu, Baogong Zhu, Nir Hacohen, Edward F. Fritsch, Vassiliki A. Boussiotis, Catherine J. Wu, Gordon J. Freeman

19.12.2018 | Original Article | Ausgabe 3/2019 Open Access

Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer

Rui Zhou, Jingwen Zhang, Dongqiang Zeng, Huiying Sun, Xiaoxiang Rong, Min Shi, Jianping Bin, Yulin Liao, Wangjun Liao

02.01.2019 | Original Article | Ausgabe 3/2019

Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater

Min Hwan Kim, Mi Jang, Hoguen Kim, Woo Jung Lee, Chang Moo Kang, Hye Jin Choi

02.01.2019 | Original Article | Ausgabe 3/2019

The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice

Hussein Sultan, Takumi Kumai, Toshihiro Nagato, Juan Wu, Andres M. Salazar, Esteban Celis

04.01.2019 | Original Article | Ausgabe 3/2019

CD73 expression in normal and pathological human hepatobiliopancreatic tissues

Amedeo Sciarra, Inês Monteiro, Christine Ménétrier-Caux, Christophe Caux, Benoit Gilbert, Nermin Halkic, Stefano La Rosa, Pedro Romero, Christine Sempoux, Laurence de Leval

11.01.2019 | Original Article | Ausgabe 3/2019

Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance

Anna Malyshkina, Elisabeth Littwitz-Salomon, Kathrin Sutter, Jean Alexander Ross, Annette Paschen, Sonja Windmann, Simone Schimmer, Ulf Dittmer

14.01.2019 | Original Article | Ausgabe 3/2019

STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes

Morten Nørgaard Andersen, Anders Etzerodt, Jonas H. Graversen, Lisa C. Holthof, Søren K. Moestrup, Marianne Hokland, Holger J. Møller

17.01.2019 | Original Article | Ausgabe 3/2019 Open Access

The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial

Charlotte M. Huijts, Sinéad M. Lougheed, Zuhir Bodalal, Carla M. van Herpen, Paul Hamberg, Metin Tascilar, John B. Haanen, Henk M. Verheul, Tanja D. de Gruijl, Hans J. van der Vliet, for the Dutch WIN-O Consortium

27.12.2018 | Clinical Trial Report | Ausgabe 3/2019 Open Access

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer

Alberto A. Chiappori, Charles C. Williams, Jhanelle E. Gray, Tawee Tanvetyanon, Eric B. Haura, Ben C. Creelan, Ram Thapa, Dung-Tsa Chen, George R. Simon, Gerold Bepler, Dmitry I. Gabrilovich, Scott J. Antonia

05.02.2019 | Correction | Ausgabe 3/2019

Correction to: CD73 expression in normal and pathological human hepatobiliopancreatic tissues

Amedeo Sciarra, Inês Monteiro, Christine Ménétrier-Caux, Christophe Caux, Benoit Gilbert, Nermin Halkic, Stefano La Rosa, Pedro Romero, Christine Sempoux, Laurence de Leval

Aktuelle Ausgaben


 

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise